Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, March 18, 2021
[ Thu, Mar 18th 2021
] - WOPRAI
[ Thu, Mar 18th 2021
] - WOPRAI
[ Thu, Mar 18th 2021
] - WOPRAI
[ Thu, Mar 18th 2021
] - WOPRAI
[ Thu, Mar 18th 2021
] - WOPRAI
[ Thu, Mar 18th 2021
] - WOPRAI
[ Thu, Mar 18th 2021
] - WOPRAI
[ Thu, Mar 18th 2021
] - WOPRAI
[ Thu, Mar 18th 2021
] - WOPRAI
[ Thu, Mar 18th 2021
] - WOPRAI
[ Thu, Mar 18th 2021
] - WOPRAI
[ Thu, Mar 18th 2021
] - WOPRAI
[ Thu, Mar 18th 2021
] - WOPRAI
[ Thu, Mar 18th 2021
] - WOPRAI
[ Thu, Mar 18th 2021
] - WOPRAI
[ Thu, Mar 18th 2021
] - WOPRAI
[ Thu, Mar 18th 2021
] - WOPRAI
[ Thu, Mar 18th 2021
] - WOPRAI
[ Thu, Mar 18th 2021
] - WOPRAI
[ Thu, Mar 18th 2021
] - WOPRAI
[ Thu, Mar 18th 2021
] - WOPRAI
[ Thu, Mar 18th 2021
] - WOPRAI
[ Thu, Mar 18th 2021
] - WOPRAI
[ Thu, Mar 18th 2021
] - WOPRAI
[ Thu, Mar 18th 2021
] - WOPRAI
[ Thu, Mar 18th 2021
] - WOPRAI
[ Thu, Mar 18th 2021
] - WOPRAI
Tejas Savant Maintained (BDSX) at Buy with Increased Target to $25 on, Mar 18th, 2021
Tejas Savant of Morgan Stanley, Maintained "Biodesix, Inc." (BDSX) at Buy with Increased Target from $20 to $25 on, Mar 18th, 2021.
Tejas has made no other calls on BDSX in the last 4 months.
There are 2 other peers that have a rating on BDSX. Out of the 2 peers that are also analyzing BDSX, 0 agree with Tejas's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Tejas
- Max Masucci of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $31 on, Tuesday, February 2nd, 2021
- Brian Weinstein of "William Blair" Initiated at Buy on, Monday, November 23rd, 2020
